Corp 104 final bundle: the GMP pharmaceutical operator kit for Mexican plant
The corp 104 final bundle equips the GMP pharmaceutical plant operator in CDMX, Estado de Mexico, Jalisco and Morelos: GMP cleanroom disposable gown complying with NOM-073-SSA1-2005 and GMP Annex 1 revision 2022, ISO 13485 medical-device documentation kit with quality manual, corporate binder for GMP training signed by STPS-registered trainer, rigid ID with GS1-128 code for ISO 7 and ISO 8 cleanroom access, and electronic badge with plant-entry traceability. The CFDI 4.0 invoice is issued under the pharmaceutical tax regime and is filed with the COFEPRIS regulatory record.
The Mexican pharmaceutical industry and its regulatory framework
Mexico is the second-largest pharmaceutical market in Latin America and the 15th worldwide per IMS Health and the Camara Nacional de la Industria Farmaceutica (CANIFARMA). The Mexican market reaches USD 12,800 million annually and operates with more than 380 national and multinational pharmaceutical laboratories producing generic, patent, biological, biotechnological drugs and medical devices. Mexican pharmaceutical plants concentrate in CDMX (Azcapotzalco, Iztapalapa), Estado de Mexico (Toluca, Naucalpan), Jalisco (Guadalajara) and Morelos (Cuernavaca).
The Mexican pharmaceutical-sector regulatory framework operates with three main institutions: the Comision Federal para la Proteccion contra Riesgos Sanitarios (COFEPRIS) is the regulatory body responsible for authorisation, health registration, inspection and surveillance of drugs, medical devices and pharmaceutical establishments; the Farmacopea de los Estados Unidos Mexicanos (FEUM) sets quality, purity and stability standards for drugs; and the Secretariat of Health (SSA) coordinates national health and pharmaceutical policy.
The Good Manufacturing Practices (GMP) regime is the international standard for drug and medical-device manufacturing. NOM-059-SSA1-2015 sets Good Manufacturing Practices for national pharmaceutical-industry establishments and is harmonised with international WHO, FDA and EMA standards. GMP European Annex 1 (revision 2022) sets requirements for sterile manufacturing with updated cleanroom-area, pressure-gradient, environmental-monitoring and contamination-control criteria.
The pharmaceutical-sector tax regime operates with 30% ISR for general-regime legal entities, 16% IVA for sale of patent drugs and medical devices, and 0% IVA for basic-table generic drugs per Article 2-A LIVA. Investment in GMP pharmaceutical plant qualifies for accelerated-investment deduction per Article 31 LISR. Invoicing to the public sector (IMSS, ISSSTE, SSA) operates with special consolidated-procurement regime governed by the Ley de Adquisiciones, Arrendamientos y Servicios del Sector Publico.
What's in the corp 104 final bundle
The kit ships in a sealed box with numbered tape and identifies the operator by name, payroll number, area (production, quality control, microbiology, aseptic filling, packaging) and shift. Delivery is signed off by the operations supervisor and documented with a barcode for inventory control in the plant's GMP system.
GMP cleanroom disposable gown NOM-073 with particle control
Single-use disposable gown manufactured in non-woven polypropylene fabric with antistatic treatment and low particle shedding (low shed per ISO 9073-10), NOM-073-SSA1-2005 compliant for pharmaceutical-staff protective clothing, GMP Annex 1 revision 2022 compliant for ISO 7 and ISO 8 cleanrooms, front closure with plastic snap buttons, V-neck collar with reinforced lapel, long sleeve with elastic at wrist, knitted cuff, reinforced knees and hips. White colour with colour code by area (blue for production, green for microbiology, yellow for maintenance). Individual packaging in sealed bag with gamma-ray sterilisation. Sizes XS to 3XL.
ISO 13485 medical-device documentation kit with quality manual
Corporate binder with 3-inch ring mechanism, capacity for 1,000 sheets, white linen-wrapped cover with gold stamping of manufacturer logo, plastic dividers for ISO 13485 quality-system sections (documentation management, risk management, supplier management, design control, validation, change control, corrective and preventive action, internal audits, management review), manufacturer quality manual, GMP Annex 1 manual, standard operating procedure (SOP) of work area, DC-3 constancia signed by STPS-registered trainer, plasticised copies of manufacturer COFEPRIS health registration. Key-locked closure for confidential filing.
Corporate GMP training binder signed STPS
Lever binder with ring mechanism, capacity for 600 sheets, washable vinyl-wrapped white cover, manufacturer seal and technical director signature, content with annual operator-training programmes (job induction, basic GMP, advanced GMP, contamination control, aseptic technique, internal audits), DC-3 constancias signed by STPS-registered trainer for each course, operator training constancias with grades, theoretical and practical evaluations, professional-development plan for operator, GMP competency registry. Recyclable material with FSC certification.
Rigid ID with GS1-128 code for cleanroom access
Professional ID badge in rigid PVC 0.76 mm with GS1-128 bar code for scanning in ISO 7 and ISO 8 cleanrooms, QR code to operator profile in GMP system with entry and exit logging, holographic anti-counterfeiting film, reinforced N52 neodymium magnetic strip, elastic breakaway safety lanyard. Colour by role (white for production, yellow for microbiology, red for visitors, blue for supervision). Personalised with name, payroll, area, shift and photo. Annual replacement or on visible wear.
GMP Annex 1 and NOM-073-SSA1-2005 compliance
GMP European Annex 1 (revision 2022) sets requirements for sterile drug manufacturing with updated cleanroom-area, pressure-gradient, environmental-monitoring and contamination-control criteria. Annex 1 compliance requires specific pieces from the corp 104 final bundle: the cleanroom disposable gown meets operator-particle shedding control, the ISO 13485 kit meets medical-device quality-management system, the training binder meets personnel GMP competency, and the GS1-128 identification meets cleanroom-area entry traceability.
NOM-073-SSA1-2005 sets minimum requirements for sterile and non-sterile drug manufacturing in Mexico. The standard applies to all national and multinational pharmaceutical plants operating in Mexico and requires: clean areas with ISO 7 and ISO 8 classification by operation, adequate staff clothing per zone, microbiological air, water and surface control, ongoing GMP personnel training, and process and analytical-method validation. The COFEPRIS audit verifies NOM-073-SSA1-2005 compliance with scheduled and unscheduled inspections.
The ISO 13485 quality-management system is the international standard for medical-device manufacturers. The standard covers the complete medical-device life cycle, from design and development to manufacturing, distribution, installation, after-sales service and final disposal. ISO 13485 compliance is required by COFEPRIS for Class I, II, III and IV medical devices, and by international regulatory bodies (FDA, EMA, Health Canada, PMDA Japan). ISO 13485 certification is audited annually by a certified auditor (BSI, TUV, SGS, Intertek).
Contamination control in cleanrooms operates with three pillars: air control (HEPA H14 filters with 99.999% efficiency for 0.3-micron particles, positive pressure gradients of 10 to 15 Pa between ISO 5, 7, 8 zones), surface control (daily cleaning and sanitisation with sporicides, alcohols, vaporised hydrogen peroxide), and personnel control (adequate clothing, aseptic training, microbiological monitoring of gloves and gowns). The GMP operator meets all three pillars and logs each entry and exit as control evidence.
Pharmaceutical invoicing and GMP tax regime
The corp 104 final bundle for the pharmaceutical operator is invoiced under CFDI USO key G03 (general expenses) with deductibility under Article 27 LISR as pharmaceutical-plant operating expense. For laboratories under legal-entity general-regime tax status, the CFDI 4.0 invoice includes the laboratory RFC and activity key 325411 (chemical-drug manufacturing). The invoice is issued with 16% IVA broken out line by line.
The 16% IVA breaks out line by line on the CFDI 4.0. For basic-table generic drugs, IVA is set at 0% under Article 2-A LIVA. For patent drugs and medical devices, 16% IVA applies without exemption. The CFDI 4.0 invoice is stamped by SAT in under 72 hours and filed with the COFEPRIS regulatory record and the plant's GMP system.
Investment in GMP pharmaceutical plant qualifies for accelerated-investment deduction per Article 31 LISR with 35% annual depreciation rate for productive fixed assets. Uniforms, personal protective equipment and GMP materials qualify as deductible operating expense per Article 27 LISR. The DC-3 training constancia signed by STPS-registered trainer is filed with the operator's tax record and COFEPRIS regulatory record.
For multinational pharmaceutical corporates with operations in Mexico (Pfizer Mexico, Bayer Mexico, AstraZeneca Mexico, Novartis Mexico, Roche Mexico, Sanofi Mexico, Boehringer Ingelheim Mexico, GlaxoSmithKline Mexico, Merck Sharp & Dohme Mexico, Johnson & Johnson Mexico, Abbott Mexico, Becton Dickinson Mexico), the kit is invoiced in MXN or USD per the intercompany policy. Conversion uses the FIX exchange rate published by Banco de Mexico on the day before the invoice. For corporates reporting to the US SEC or European equivalent, the kit expense is reported as pharmaceutical operating expense in the annual report and attached to the corporate ESG report.
Pharmaceutical logistics and GMP plant delivery
The corp 104 final bundle's main distribution centre sits in CDMX (for CDMX, Estado de Mexico, Morelos plants) or in Guadalajara (for Jalisco plants), with road coverage to pharmaceutical plants in Toluca, Naucalpan, Cuernavaca, Guadalajara and Queretaro. For urgent deliveries with less than 5 business days' notice, air freight is available from CDMX airport or Guadalajara airport. The courier complies with NOM-251 and with GMP requirements for shipping uniforms and GMP materials.
Pharmaceutical-plant delivery goes to the quarantine area of the corporate's PPE warehouse with sign-off by the operations supervisor and photographic capture of received material. The courier meets chain-of-custody requirements for GMP materials and carries cargo insurance for the declared kit value. Delivery is scheduled during business hours (8:00 to 17:00) to avoid affecting pharmaceutical production and to allow the supervisor's sign-off.
For recurring weekly or monthly deliveries to a single plant, an annual contract is established with 30-day advance scheduling and safety stock equivalent to one month of consumption at the plant's GMP warehouse. Automatic replenishment kicks in when inventory drops below the reorder point agreed with the operations area. Delivery is signed by the operations supervisor or authorised representative and filed with the plant's GMP record for COFEPRIS compliance.
For multinational pharmaceutical corporates with plants in Mexico (Pfizer Toluca, Bayer Lerma, AstraZeneca Lomas Verdes, Novartis CDMX, Roche Mexico City), we coordinate deliveries with a single point of contact from CDMX or Guadalajara. The invoice is issued consolidated by corporate with breakdown by plant and by operator, in MXN or USD per the intercompany policy. Standard delivery runs 3 business days for CDMX, Estado de Mexico and Morelos plants, and 5 business days for Guadalajara, Queretaro and other cities.
FAQ — corp 104 final bundle
Does the disposable gown meet GMP Annex 1 and NOM-073?
Yes. The corp 104 final disposable gown meets NOM-073-SSA1-2005 for pharmaceutical-staff protective clothing and GMP Annex 1 revision 2022 for sterile manufacturing in ISO 7 and ISO 8 cleanrooms. The non-woven polypropylene fabric has antistatic treatment and low particle shedding (low shed per ISO 9073-10), and ships in sealed bag with gamma-ray sterilisation. The GMP and NOM-073 certificates are filed with the operator's record and renew annually.
Does the ISO 13485 kit cover the medical-device life cycle?
Yes. The corp 104 final ISO 13485 kit covers the complete medical-device life cycle, from design and development to manufacturing, distribution, installation, after-sales service and final disposal. The binder includes quality manual, GMP Annex 1 manual, standard operating procedures (SOP) of work area, and DC-3 constancias signed by STPS-registered trainer. The ISO 13485 audit runs annually by a certified auditor (BSI, TUV, SGS, Intertek).
Does the GS1-128 badge work for ISO 7 and ISO 8 cleanrooms?
Yes. The corp 104 final badge includes GS1-128 bar code for scanning in ISO 7 and ISO 8 cleanrooms and QR code to the operator profile in the GMP system with entry and exit logging. Cleanroom-entry traceability meets Annex 1 revision 2022 and NOM-073-SSA1-2005. The COFEPRIS audit verifies cleanroom-entry traceability as part of the GMP inspection.
Do you handle small plants and contract manufacturers?
Yes. The corp 104 final bundle adapts to small pharmaceutical plants and contract manufacturers (CMO) with MOQ from 15 operators. Binder and folder personalisation is quoted separately for small volumes, and production lead time drops to 7 business days for urgent orders. Delivery goes direct to the GMP warehouse with specialised courier and sign-off by the operations supervisor. The invoice is issued in MXN with deductibility as plant operating expense.
How is the GMP pharmaceutical regime invoiced?
For laboratories under legal-entity general-regime tax status, the CFDI 4.0 invoice includes the laboratory RFC and activity key 325411 (chemical-drug manufacturing). The 16% IVA breaks out line by line and is set at 0% for basic-table generic drugs per Article 2-A LIVA. Investment in GMP plant qualifies for accelerated-investment deduction per Article 31 LISR. The DC-3 constancia signed by STPS trainer is filed with the operator's tax record and COFEPRIS regulatory record.
Can you deliver before COFEPRIS audit?
Yes. For deliveries before COFEPRIS audit with less than 15 business days' notice, we offer express service with priority production and air freight from CDMX or Guadalajara. The express service charge is 35% over the kit base price and delivery runs 3 to 5 business days. Advance scheduling of 60 days for programmed deliveries is the recommended option to avoid express charges and secure production capacity without affecting GMP plant supply.